Evidence map›Paper›PMID 36703327›Full record

ArticleCommunications chemistry2020

High-throughput screening for discovery of benchtop separations systems for selected rare earth elements.

Joshua J M Nelson, Thibault Cheisson, Haley J Rugh, Michael R Gau, Patrick J Carroll, Eric J Schelter

Abstract read
In one paragraph

Article in Communications chemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Parallel and High Throughput Reaction Monitoring with Computer Vision.Angewandte Chemie (International ed. in English) · 2025
    Article
  4. Rare Earths-The Answer to Everything.Molecules (Basel, Switzerland) · 2024
    Review
  5. Multiple Rounds ofACS synthetic biology · 2023
    Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Joshua J M NelsonP. Roy and Diana T. Vagelos Laboratories, Department of Chemistry, University of Pennsylvania, 231S. 34th Street, Philadelphia, PA, 19104, USA.ORCID http://orcid.org/0000-0002-5510-6545
Thibault CheissonP. Roy and Diana T. Vagelos Laboratories, Department of Chemistry, University of Pennsylvania, 231S. 34th Street, Philadelphia, PA, 19104, USA.ORCID http://orcid.org/0000-0003-4359-5115
Haley J RughP. Roy and Diana T. Vagelos Laboratories, Department of Chemistry, University of Pennsylvania, 231S. 34th Street, Philadelphia, PA, 19104, USA.ORCID http://orcid.org/0000-0002-9048-893X
Michael R GauP. Roy and Diana T. Vagelos Laboratories, Department of Chemistry, University of Pennsylvania, 231S. 34th Street, Philadelphia, PA, 19104, USA.
Patrick J CarrollP. Roy and Diana T. Vagelos Laboratories, Department of Chemistry, University of Pennsylvania, 231S. 34th Street, Philadelphia, PA, 19104, USA.
Eric J SchelterP. Roy and Diana T. Vagelos Laboratories, Department of Chemistry, University of Pennsylvania, 231S. 34th Street, Philadelphia, PA, 19104, USA. schelter@sas.upenn.edu.ORCID http://orcid.org/0000-0002-8143-6206

Funding

DOE | SC | Basic Energy Sciences (BES) DE-SC0016568
6 · The paper itself

Abstract

Rare earth (RE) elements (scandium, yttrium, and the lanthanides) are critical for their role in sustainable energy technologies. Problems with their supply chain have motivated research to improve separations methods to recycle these elements from end of life technology. Toward this goal, we report the synthesis and characterization of the ligand tris[(1-hydroxy-2-oxo-1,2-dihydropyridine-3-carboxamido)ethyl]amine, H

Identifiers

PMID36703327
PMCPMC9814905

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.